In this study, we showed that treatment of gallbladder carcinoma SGC-996 cells with the HDAC inhibitors TSA and SAHA resulted in loss of cell viability and induction of apoptosis, accompanied with G1-phase cell cycle arrest. This evidence concerns the gene HDAC9 and gallbladder carcinoma.